Biocept (NASDAQ: BIOC)
$0.00
(0.0%)
$0.00
Price as of April 15, 2024, 10:15 a.m. ET
Biocept Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Biocept Company Info
Biocept, Inc. is an oncology laboratory service company, which engages in the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. The company was founded on May 12, 1997 and is headquartered in San Diego, CA.
News & Analysis
Featured Article
Why RH, Biocept, and Lowe's Jumped Today
One of these companies said investors shouldn't worry about proposed China tariffs.
Steve Symington | Jul 13, 2018
Featured Article
Why Biocept, Inc. Is Rebounding Big-Time Today
The molecular diagnostics company inked a new distribution deal that helped investors forget yesterday's bad news.
Keith Speights | Jul 13, 2018
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.